Yakup Ergün/X
Jan 2, 2025, 15:54
Yakup Ergün: Final Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X:
“Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
“Among patients who had been alive and progression-free at 3 years, 10-year melanoma-specific survival was 96% with nivolumab plus ipilimumab, 97% with nivolumab, and 88% with ipilimumab”
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
Authors: Jedd D. Wolchok et al.
Andrew G. Hill
Ayman Nassar
C. Lance Cowey
cancer
Caroline Gaudy-Marqueste
Céleste Lebbé
Christopher D Lao
Corey Ritchings
Dirk Schadendorf
F. Stephen Hodi
Georgina V. Long
Ivan Marquez-Rodas
James Larkin
Jedd D. Wolchok
John B.A.G. Haanen
John Wagstaff
John Walker
Marcus O. Butler
Margarita Askelson
Massimo Guidoboni
Matteo S Carlino
Melanie Pe Benito
Michael A. Postow
Michele Maio
OncoDaily
Oncology
Paola Queirolo
Paolo A. Ascierto
Patrick Schöffski
Piotr Rutkowski
Reinhard Dummer
Shahneen Sandhu
Theresa Medina
Vanna Chiarion Sileni
Wenjia Wang
Yakup Ergün
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 2, 2025, 15:53
Jan 2, 2025, 15:51
Jan 2, 2025, 15:49
Jan 2, 2025, 15:29
Jan 2, 2025, 15:26